MedTrace Logo

Autologous Fat Grafting of the Breast in Women With Post Lumpectomy Contour Defects

NCT02302196 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 27

Last updated 2021-08-20

No results posted yet for this study

Summary

The purpose of the study is to evaluate the safety and efficacy of breast reconstruction using Autologous Fat Grafting (AFG) for women post lumpectomy that have contour defects.

The study hypothesis is that AFG has emerged as a less invasive alternative to breast reconstruction post mastectomy. AFG could be used to treat breast contour defects with much less invasive outpatient surgery, using the patient's own cells and tissues, which overall reduces risk.

Conditions

  • Cancer of the Breast
  • Anomaly of Breast

Interventions

PROCEDURE

Autologous Fat Grafting of the Breast

In fat grafting, fat tissue is removed from other parts of the body; usually thighs, belly, and buttocks by liposuction. The tissue is then processed and injected into the breast area to reconstruct or recreate the breast. The fat will be removed from by a narrow surgical instrument (cannula) through a small incision. Then the fat will be prepared in a specific way before being replaced back in the body. This preparation may include washing, filtering, and centrifugation (spinning) of the fat. The fat is then placed into the desired area of the breast using either a smaller cannula or needle.

OTHER

Control Arm

Retrospective chart review for women who have undergone standard breast reconstruction for lumpectomy.

Sponsors & Collaborators

  • Kaiser Permanente

    lead OTHER

Principal Investigators

  • Jennifer Murphy, MD · Kaiser Permanente Northwest Region

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-09-30
Primary Completion
2021-07-13
Completion
2021-07-13

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02302196 on ClinicalTrials.gov